59 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 59 of 59 clinical reviews.
Aetna (CVS Health) covers testosterone enanthate for diagnosed male hypogonadism with prior authorization. Learn formulary tier, step therapy requirements, PA criteria, and how to appeal a denial.
Find out whether Cigna covers testosterone enanthate for hypogonadism, what prior authorization criteria apply, which formulary tier it sits on, and how to appeal a denial.
Find out whether Humana covers testosterone enanthate for hypogonadism, what prior authorization criteria apply, which formulary tier it sits on, and how to appeal a denial.
Medicare Advantage plans generally cover testosterone enanthate for diagnosed male hypogonadism. Learn about formulary tiers, prior authorization requirements, step therapy, and how to appeal a denial.
State Medicaid coverage for testosterone enanthate varies widely. Learn which states cover it, prior authorization requirements, formulary tiers, appeal processes, and how to reduce out-of-pocket costs.
TRICARE covers testosterone enanthate for diagnosed male hypogonadism. Learn formulary tier, prior authorization criteria, step therapy rules, copay costs, and how to appeal a denial.
Find out whether UnitedHealthcare covers testosterone enanthate for hypogonadism, including formulary tier placement, prior authorization criteria, step therapy rules, and how to appeal a denial.
Testosterone enanthate is made by attaching an enanthoic acid ester to testosterone, extending its half-life to about 4.5 days. FDA-approved in 1954 as Delatestryl.
A comprehensive clinical review of testosterone enanthate use in patients with autoimmune conditions, covering immunomodulatory mechanisms, disease-specific risks, dosing considerations, and monitoring protocols backed by primary literature.
A clinical review of testosterone enanthate's effects on cognition, memory, and mood in hypogonadal men, covering the T-Trials, mechanistic data, dosing, and monitoring protocols.
A guide to how testosterone enanthate affects appetite, hunger hormones, and food cravings in men with hypogonadism, with primary-literature citations throughout.
An evidence-based guide to how testosterone enanthate affects bone mineral density, fracture risk, and skeletal health in men with hypogonadism, with primary-literature citations throughout.
Compare testosterone enanthate pricing against cypionate, undecanoate, topical gels, oral capsules, nasal gel, and pellets. Includes per-month costs, insurance coverage patterns, and clinical equivalence data.
Evidence-based testosterone enanthate dosing guide for adults aged 30 to 49 with confirmed hypogonadism. Covers starting doses, titration, injection frequency, lab targets, and when to adjust.
Clinical dosing guidance for testosterone enanthate in adults aged 50-64, including starting doses, titration protocols, monitoring labs, and cardiovascular safety considerations.
Clinical guide to testosterone enanthate dosing in young men aged 18 to 29, covering starting doses, fertility preservation with hCG, monitoring labs, and long-term safety.
Evidence-based guide to testosterone enanthate dose adjustment in liver disease, covering pharmacokinetics, monitoring, and safety in mild, moderate, and severe hepatic impairment.
What renal impairment changes in testosterone-enanthate decision-making, and why a general page cannot prescribe a CKD dose or monitoring protocol.
A guide to every clinically significant drug interaction with testosterone enanthate, including anticoagulants, insulin, corticosteroids, and CYP450-mediated conflicts.
Evidence-based guide to food and supplement interactions with testosterone enanthate, including effects on absorption, metabolism, and clinical outcomes.
Testosterone enanthate is an FDA-approved intramuscular injection for male hypogonadism. Learn about clinical evidence from the T-Trials, standard dosing protocols, side effects, and monitoring requirements.
Evidence-based guide to testosterone enanthate for secondary hypogonadism: FDA status, dosing protocols, clinical trial data, side effects, and when fertility-sparing alternatives are preferred.
A clinical deep-dive into what comes next for testosterone enanthate: novel delivery routes, extended-release depots, subdermal implants, nasal gels, oral prodrugs, and late-stage pipeline candidates reshaping male hypogonadism care.
Evidence-based guide to testosterone enanthate dosing in men 65 and older, covering starting doses, titration, cardiovascular monitoring, and when to adjust or stop therapy.
Evidence-based monitoring guide for testosterone enanthate in men 65 and older, covering lab timing, hematocrit thresholds, cardiovascular screening, bone density tracking, and deprescribing criteria.
A clinician-level review of how testosterone enanthate affects scalp hair, body hair, sebum production, acne, and skin thickness. Covers mechanisms, timelines, management strategies, and primary-literature citations.
Evidence-based safety guide for testosterone enanthate use in men aged 65 and older, covering cardiovascular risk, polycythemia, falls, drug interactions, and monitoring protocols.
Evidence-based guide to testosterone enanthate use in transplant recipients, HIV/AIDS patients, and other special populations, with dosing, monitoring, and safety data from primary sources.
A clinical deep-dive into testosterone enanthate manufacturing processes, supply chain dynamics, and the history of drug shortages affecting TRT patients in the United States.
MD-level explanation of how testosterone enanthate works, from ester hydrolysis and depot release through androgen receptor binding, gene transcription, and downstream physiologic effects. PubMed-cited.
A clinician-level review of how testosterone enanthate affects depression, anxiety, cognition, and mood in hypogonadal men, with primary-literature citations, dosing context, and monitoring guidance.
A guide to testosterone enanthate missed-dose management, pharmacokinetics, injection timing, and how the drug works at the molecular level.
A clinical guide to monitoring testosterone enanthate therapy in adults aged 30 to 49, covering lab schedules, dose adjustments, cardiovascular markers, hematocrit, fertility, and when to escalate care.
Evidence-based monitoring protocol for testosterone enanthate in men aged 50-64, covering lab timing, hematocrit thresholds, cardiovascular screening, PSA tracking, and bone density assessment.
Evidence-based monitoring protocol for testosterone enanthate in young adults aged 18 to 29, covering baseline labs, fertility preservation, hematocrit, cardiovascular markers, and long-term follow-up schedules.
Evidence-based testosterone enanthate muscle preservation strategies covering dosing, resistance training protocols, nutrition, and monitoring. Reviewed by board-certified physicians.
A clinician-grade review of testosterone enanthate off-label applications, from female hypoactive sexual desire disorder to HIV-associated wasting, organized by strength of evidence and monitoring burden.
What happens if you take too much testosterone enanthate? A guide covering overdose symptoms, acute management, long-term risks of supraphysiologic dosing, and when to seek emergency care.
A clinician-grade review of testosterone enanthate's patent history, generic availability, FDA-approved formulations, and what the post-patent market means for prescribers and patients.
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4 shape testosterone enanthate pharmacokinetics, efficacy, and side-effect risk, with dosing implications for clinical practice.
A clinical breakdown of testosterone enanthate absorption, distribution, metabolism, and excretion, with half-life data, peak serum timing, and dosing implications.
A physician-level guide to diagnosing and resolving testosterone enanthate plateaus, including dose timing, injection technique, lab interpretation, and conversion strategies backed by primary literature.
How long to hold testosterone enanthate before surgery, why the pause matters for clotting and hemodynamic risk, and how to restart TRT safely post-op, a physician-level clinical reference.
A clinician-focused review of testosterone enanthate real-world evidence from registries, VA databases, and long-term observational cohorts, including the T-Trials, TRAVERSE, and European registry data.
A breakdown of testosterone enanthate's legal status, scheduling, approved indications, and prescribing rules across the United States, European Union, Canada, and United Kingdom, with primary-source citations throughout.
Evidence-based safety profile of testosterone enanthate for men aged 30, 49, covering cardiovascular risk, hematologic monitoring, fertility impact, and FDA-mandated warnings.
Evidence-based safety profile of testosterone enanthate for men aged 50 to 64, covering cardiovascular risk, polypharmacy, PSA monitoring, and clinical trial data.
Evidence-based safety profile of testosterone enanthate in young adults aged 18-29, covering fertility risks, cardiovascular monitoring, hematocrit thresholds, and clinical guidelines for safe prescribing.
A comprehensive analysis of testosterone enanthate safety signals, FDA regulatory actions, cardiovascular risk, polycythemia, and clinical monitoring protocols backed by primary trial data.
Step-by-step testosterone enanthate self-injection technique with MD-level depth: site selection, needle choice, aspiration debate, dosing schedules, and safety monitoring backed by PubMed and FDA citations.
How to store testosterone enanthate: keep vials at 20-25°C (68-77°F) in the original carton, away from light, and discard 28 days after first puncture.
Complete clinical guide to managing testosterone enanthate injections during travel, time-zone changes, and schedule disruptions. Covers dose timing flexibility, storage, customs documentation, and injection technique on the road.
Evidence-based protocol for discontinuing testosterone enanthate, including tapering strategies, PCT options, HPTA recovery timelines, and monitoring labs.
A clinician-level review of testosterone enanthate safety during pregnancy and lactation, covering teratogenic risk, fetal virilization, breast-milk transfer, and evidence-based alternatives for women with low testosterone.
A practical guide to restarting testosterone enanthate (TE) injections after acute illness, covering when to hold, how to restart, dose adjustments, and monitoring, with clear notes on what is established versus what needs primary-source verification.
A guide to switching testosterone enanthate to or from cypionate, undecanoate, pellets, and topicals. Covers pharmacokinetics, washout timing, dose conversion, and monitoring protocols with PubMed and FDA citations.
A week-by-week guide to what happens during your first month on testosterone enanthate, including timelines, clinical data, lab targets, and side-effect management.
AUA guideline data on exogenous testosterone and spermatogenesis suppression, with HPG axis recovery timelines from 3 to 24+ months after stopping.
Baseline labs, then follow-up at 6 to 12 weeks, then every 6 to 12 months once stable. See what tests are checked and target trough levels.